FUSE SCIENCE, INC.

Profile

Company Names

FUSE SCIENCE, INC.
DOUBLE EAGLE HOLDINGS, LTD.

Addresses

65510 MERRICK RD., MASSAPEQUA, NY 11758

6135 NW 167TH STREET, #E-21, MIAMI LAKES, FL 33015

6135 NW 167TH STREET, #E21, MIAMI LAKES, FL 33015

20900 NE 30TH AVENUE, EIGHTH FLOOR, AVENTURA, FL 33180

4500 CAMERON VALLEY PARKWAY, SUITE 270, CHARLOTTE, NC 28211

20900 NE 30TH AVENUE, 8TH FLOOR, AVENTURA, FL 33180

Phone Numbers

516-659-7558
305-503-3873
704-366-5122

 

Entity Type:

CORPORATION

Industry:

OTHER, OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$11,114,359.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2014-10-01 
$1,600,000.00 
$1,600,000.00 
$0.00 
Equity 
9
2014-01-03 
$1,775,000.00 
$1,775,000.00 
$0.00 
Debt 
8
2013-11-07 
$700,000.00 
$700,000.00 
$0.00 
Debt 
7
2013-03-04 
$2,050,000.00 
$2,050,000.00 
$0.00 
Debt 
6
2012-02-09 
$3,169,359.00 
$3,169,359.00 
$0.00 
Debt 
5
2012-01-09 
$550,000.00 
$550,000.00 
$0.00 
 
4
2011-12-29 
$185,000.00 
$185,000.00 
$0.00 
 
3
2011-09-09 
$540,000.00 
$540,000.00 
$0.00 
 
2
2011-06-20 
$525,000.00 
$525,000.00 
$0.00 
 
1
2011-05-12 
$20,000.00 
$400,000.00 
$380,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADAM 
 
ADLER 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
BERKOFF 
DIRECTOR
DAVID 
J. 
BERKOFF 
DIRECTOR
JOANNE 
 
BRANDES 
DIRECTOR
NEIL 
 
CHIN 
DIRECTOR
JAMES 
 
FREDERICK 
DIRECTOR
EZRA 
 
GREEN 
EXECUTIVE OFFICER
RUBIN 
 
HANAN 
EXECUTIVE OFFICER
RICARDO 
 
HARRIS 
DIRECTOR
JEANNE 
 
HEBERT 
EXECUTIVE OFFICER, DIRECTOR
REGINALD 
 
HOLLINGER 
DIRECTOR
RICHARD 
 
HUTCHINGS 
DIRECTOR
RICHARD 
S. 
HUTCHINGS 
DIRECTOR
RICHARD 
 
HUTCHINS 
DIRECTOR
BRIAN 
 
TUFFIN 
EXECUTIVE OFFICER, DIRECTOR
AITAN 
 
ZACHARIN 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Equity 
2014-10-01 
D
OTHER TECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Debt 
2014-01-03 
D
OTHER TECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
$1 - $1,000,000 
Debt 
2013-11-07 
D
OTHER 
INVESTORS, NEC [6799] 
$1 - $1,000,000 
Debt 
2013-03-04 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
Debt 
2012-02-09 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2011-12-29 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2012-01-09 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2011-09-09 
D/A
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2011-06-20 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2011-06-20 
D
OTHER 
INVESTORS, NEC [6799] 
NO REVENUES 
 
2011-05-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
DAWSON JAMES SECURITIES INC
DAWSON JAMES SECURITIES INC.
NATIONAL SECURITIES CORPORATION
NONE
NONE
NATIONAL SECURITIES CORPORATION